000028 国药一致
交易中 03-11 14:56:57
资讯
新帖
简况
国药一致:公司尚未开展DeepSeek方面的部署
证券之星 · 03-10 16:00
国药一致:公司尚未开展DeepSeek方面的部署
国药一致最新公告:聘任王矗为公司副总经理
证券之星 · 03-05
国药一致最新公告:聘任王矗为公司副总经理
国药一致:公司2024年三季度报告中披露2024年9月30日公司股东人数为32,954人
证券之星 · 02-18
国药一致:公司2024年三季度报告中披露2024年9月30日公司股东人数为32,954人
国药一致:公司将在相关业务领域积极使用新技术,推动科技赋能
证券之星 · 02-18
国药一致:公司将在相关业务领域积极使用新技术,推动科技赋能
每周股票复盘:国药一致(000028)修订公司章程并调整多项业务
证券之星 · 02-15
每周股票复盘:国药一致(000028)修订公司章程并调整多项业务
【机构调研记录】长盛基金调研国药一致、汇绿生态等3只个股(附名单)
证券之星 · 01-22
【机构调研记录】长盛基金调研国药一致、汇绿生态等3只个股(附名单)
【机构调研记录】浦银安盛基金调研仙鹤股份、国药一致等3只个股(附名单)
证券之星 · 01-22
【机构调研记录】浦银安盛基金调研仙鹤股份、国药一致等3只个股(附名单)
【机构调研记录】红土创新基金调研国药一致
证券之星 · 01-22
【机构调研记录】红土创新基金调研国药一致
【机构调研记录】国泰基金调研仙鹤股份、国药一致等5只个股(附名单)
证券之星 · 01-22
【机构调研记录】国泰基金调研仙鹤股份、国药一致等5只个股(附名单)
【机构调研记录】博远基金调研国药一致
证券之星 · 01-22
【机构调研记录】博远基金调研国药一致
国药一致:公司坚持夯实主业,提升盈利水平,每年实施现金分红
证券之星 · 01-21
国药一致:公司坚持夯实主业,提升盈利水平,每年实施现金分红
国药一致:1月20日召开分析师会议,中金证券、开源证券等多家机构参与
证券之星 · 01-21
国药一致:1月20日召开分析师会议,中金证券、开源证券等多家机构参与
国药一致(000028)1月20日主力资金净卖出2684.09万元
证券之星 · 01-21
国药一致(000028)1月20日主力资金净卖出2684.09万元
国药控股:国药一致预计2024年归母净利润约5.61亿至7.6亿元同比下降52.48%至64.92%
新浪港股 · 01-20
国药控股:国药一致预计2024年归母净利润约5.61亿至7.6亿元同比下降52.48%至64.92%
国药控股(01099.HK)附属国药一致预计全年盈利跌逾52.5%
阿斯达克财经 · 01-19
国药控股(01099.HK)附属国药一致预计全年盈利跌逾52.5%
【国药一致预计2024年归母净利约5.61亿元-7.6亿元 同比下降52.48%-64.92%】国药一致预计2024年归属于上市公司股东的净利润为约5.61亿元-7.6亿元,同比下降52.48%-64.92%;预计扣非净利约4.97亿-6.96亿元,同比下降54.59%-67.58%。
金融界 · 01-19
【国药一致预计2024年归母净利约5.61亿元-7.6亿元 同比下降52.48%-64.92%】国药一致预计2024年归属于上市公司股东的净利润为约5.61亿元-7.6亿元,同比下降52.48%-64.92%;预计扣非净利约4.97亿-6.96亿元,同比下降54.59%-67.58%。
国药控股(01099.HK):国药一致2024年度净利润预降52.48%-64.92%
格隆汇 · 01-19
国药控股(01099.HK):国药一致2024年度净利润预降52.48%-64.92%
国药控股(01099):国药一致(000028.SZ)预计2024年归母净利约5.61亿元-7.6亿元 同比下降52.48%-64.92%
智通财经 · 01-19
国药控股(01099):国药一致(000028.SZ)预计2024年归母净利约5.61亿元-7.6亿元 同比下降52.48%-64.92%
国药控股:国药一致2024年度净利润预亏,预计下降52.48%-64.92%
金融界 · 01-19
国药控股:国药一致2024年度净利润预亏,预计下降52.48%-64.92%
国药一致(000028.SZ)发预减 2024年度净利润5.61亿–7.6亿元 同比下降52.48%-64.92%
智通财经 · 01-17
国药一致(000028.SZ)发预减 2024年度净利润5.61亿–7.6亿元 同比下降52.48%-64.92%
加载更多
公司概况
公司名称:
国药集团一致药业股份有限公司
所属行业:
批发业
上市日期:
1993-08-09
主营业务:
国药集团一致药业股份有限公司是集制药工业、医药批发、零售连锁为一体的医药上市公司,控股股东为国药控股有限公司。主要经营医药企业受托管理、资产重组,医药实业投资项目的咨询服务,举办医疗器械的展览展销,中药材、中成药、中药饮片、化学原料药、化学药制剂、抗生素、生化药品、生物制品的批发(经营期限以许可证为准)。公司坚持走研发、制药、分销、物流、零售一体化发展道路,旗下拥有致君制药、万乐公司、一致药店等公司,其中一致药店为国内最大规模的连锁药店之一,公司属下国大药房是全国销售规模领先的医药零售企业,是国内少数拥有全国性直营药品零售网络的企业之一。
发行价格:
3.50
{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":26.41,"timestamp":1741676217000,"preClose":26.49,"halted":0,"volume":3538670,"delay":0,"changeRate":-0.003,"floatShares":478000000,"shares":557000000,"eps":2.6505,"marketStatus":"交易中","change":-0.08,"latestTime":"03-11 14:56:57","open":26.33,"high":26.48,"low":26.09,"amount":93057300,"amplitude":0.0147,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":2.6505,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741676400000},"marketStatusCode":2,"adr":0,"adjPreClose":26.49,"symbolType":"stock","openAndCloseTimeList":[[1741656600000,1741663800000],[1741669200000,1741676400000]],"highLimit":29.14,"lowLimit":23.84,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"isCdr":false,"pbRate":0.81,"roa":"--","peRate":9.964158,"roe":"5.99%","epsLYR":2.87,"committee":0,"marketValue":14699000000,"turnoverRate":0.0074,"status":1,"floatMarketCap":12625000000},"requestUrl":"/m/hq/s/000028","defaultTab":"news","newsList":[{"id":"2518294082","title":"国药一致:公司尚未开展DeepSeek方面的部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2518294082","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518294082?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:00","pubTimestamp":1741593645,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致03月10日在投资者关系平台上答复投资者关心的问题。请问贵公司是否已经部署了DeepSeek?公司接入DeepSeek有哪些成本、收益方面的考量?如果公司计划在未来再进行部署,计划将DeepSeek应用于什么具体的业务呢?公司始终秉持开放合作的态度,持续密切关注前沿技术的发展和运用,探索与科技企业在智慧医疗、供应链管理等领域的潜在合作机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000019045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2517960685","title":"国药一致最新公告:聘任王矗为公司副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960685","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517960685?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:23","pubTimestamp":1741163029,"startTime":"0","endTime":"0","summary":"国药一致(000028.SZ)公告称,同意聘任王矗为公司副总经理。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500027560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0250","BK0185","BK0028","BK0188","BK0196","BK0175","BK0010","000028"],"gpt_icon":0},{"id":"2512913761","title":"国药一致:公司2024年三季度报告中披露2024年9月30日公司股东人数为32,954人","url":"https://stock-news.laohu8.com/highlight/detail?id=2512913761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512913761?lang=zh_cn&edition=full","pubTime":"2025-02-18 18:00","pubTimestamp":1739872843,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致02月18日在投资者关系平台上答复投资者关心的问题。投资者:请问截止2025年2月20日,股东人数有多少?根据信息披露公平性原则,公司会按照相关规定在定期报告披露期末股东人数。公司2024年三季度报告中披露2024年9月30日公司股东人数为32,954人,谢谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021800033221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0082","BK0028","BK0185","BK0196","BK0188","BK0175","BK0250","000028"],"gpt_icon":0},{"id":"2512213417","title":"国药一致:公司将在相关业务领域积极使用新技术,推动科技赋能","url":"https://stock-news.laohu8.com/highlight/detail?id=2512213417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512213417?lang=zh_cn&edition=full","pubTime":"2025-02-18 17:30","pubTimestamp":1739871018,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致(000028)02月18日在投资者关系平台上答复投资者关心的问题。投资者:董秘,你好!请问我们国药一致在分销,专业药房,国大药房,spd项目等领域,是否已经或者准备考虑使用AI技术来,提高运营质量和效率?如果有,能否披露一下。感谢!国药一致董秘:感谢您的关注。公司将在相关业务领域积极使用新技术,推动科技赋能。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021800030494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0082","BK0010","BK0175","BK0028","000028","BK0188","BK0185","BK0250"],"gpt_icon":0},{"id":"2511643625","title":"每周股票复盘:国药一致(000028)修订公司章程并调整多项业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2511643625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511643625?lang=zh_cn&edition=full","pubTime":"2025-02-15 06:17","pubTimestamp":1739571430,"startTime":"0","endTime":"0","summary":"截至2025年2月14日收盘,国药一致报收于26.32元,较上周的26.0元上涨1.23%。本周,国药一致2月14日盘中最高价报26.59元。该议案需提交股东大会审议。关于召开2025年第二次临时股东大会通知的公告国药集团一致药业股份有限公司将于2025年2月28日14:30召开2025年第二次临时股东大会,会议地点为深圳市福田区八卦四路15号一致药业大厦5楼会议室。股权登记日为2025年2月24日,B股股东应在2025年2月19日前买入公司股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500009380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0175","BK0250","BK0188","BK0010","BK0196","BK0185","BK0028","BK0082"],"gpt_icon":0},{"id":"2505734245","title":"【机构调研记录】长盛基金调研国药一致、汇绿生态等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505734245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505734245?lang=zh_cn&edition=full","pubTime":"2025-01-22 08:03","pubTimestamp":1737504239,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及1月21日披露的机构调研信息,长盛基金近期对3家上市公司进行了调研,相关名单如下:1)国药一致 个股亮点:B股:一致B于1993-08-09上市;公司携手腾讯公司,与3家医院签订了“互联网+智慧医院”合作框架协议;公司是国内较早研发冷链管理软硬件系统的企业,技术先进、成熟稳定,安全可靠2)汇绿生态 个股亮点:公司持有武汉钧恒30%的股权,标的有400G、800G高速光模块产品,已实现批量交付。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200007809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0082","BK0277","BK0028","BK0185","BK0196","001267","BK0188","BK0175","BK0250","000028"],"gpt_icon":0},{"id":"2505734756","title":"【机构调研记录】浦银安盛基金调研仙鹤股份、国药一致等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505734756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505734756?lang=zh_cn&edition=full","pubTime":"2025-01-22 08:03","pubTimestamp":1737504228,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及1月21日披露的机构调研信息,浦银安盛基金近期对3家上市公司进行了调研,相关名单如下:1)仙鹤股份 个股亮点:鹤21转债于2021-12-09上市;公司的电气及工业用纸系列主要为电解电容器纸等绝缘材料用纸,用于隔绝电容器内部正负极及吸收电解液,保证电容器处于正常工作状态。旗下最近一年表现最佳的公募基金产品为浦银安盛科技创新优选混合,最新单位净值为1.2,近一年增长57.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200007797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","603733","BK0185","BK0188","BK0196","BK0250","BK0175","BK0222","BK0010","BK0028","BK0082"],"gpt_icon":0},{"id":"2505673478","title":"【机构调研记录】红土创新基金调研国药一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2505673478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505673478?lang=zh_cn&edition=full","pubTime":"2025-01-22 08:03","pubTimestamp":1737504228,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为红土创新新科技股票,最新单位净值为2.72,近一年增长42.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200007798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","000028","BK0028","BK0010","BK0185","BK0250","BK0188","BK0175","BK0196"],"gpt_icon":0},{"id":"2505734210","title":"【机构调研记录】国泰基金调研仙鹤股份、国药一致等5只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505734210","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505734210?lang=zh_cn&edition=full","pubTime":"2025-01-22 08:02","pubTimestamp":1737504176,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及1月21日披露的机构调研信息,国泰基金近期对5家上市公司进行了调研,相关名单如下:1)仙鹤股份 个股亮点:鹤21转债于2021-12-09上市;公司的电气及工业用纸系列主要为电解电容器纸等绝缘材料用纸,用于隔绝电容器内部正负极及吸收电解液,保证电容器处于正常工作状态。旗下最近一年表现最佳的公募基金产品为国泰智享科技1个月滚动持有混合发起A,最新单位净值为1.04,近一年增长53.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200007762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","603733","BK0185","BK0188","BK0196","BK0250","BK0175","BK0222","BK0010","BK0028","BK0082"],"gpt_icon":0},{"id":"2505734724","title":"【机构调研记录】博远基金调研国药一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2505734724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505734724?lang=zh_cn&edition=full","pubTime":"2025-01-22 08:02","pubTimestamp":1737504170,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为博远增强回报债券A,最新单位净值为0.9,近一年增长7.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200007753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0175","BK0028","BK0188","BK0250","BK0185","BK0196","BK0010","BK0082"],"gpt_icon":0},{"id":"2505299648","title":"国药一致:公司坚持夯实主业,提升盈利水平,每年实施现金分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2505299648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505299648?lang=zh_cn&edition=full","pubTime":"2025-01-21 12:30","pubTimestamp":1737433832,"startTime":"0","endTime":"0","summary":"公司坚持夯实主业,不断“练好内功”,提升公司盈利水平,每年实施现金分红;另一方面,将继续加强与资本市场投资者的沟通,积极有效地向市场传递公司经营发展成果,让公司内在价值在资本市场市值上体现。投资者:公司公告称将计提8.76亿元到10.07亿元商誉减值。以及上一次公告的几个公司破产清算。公司有相关管理制度和考核机制进行约束,同时也将结合市场环境变化,努力改善经营质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100016251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0185","BK0250","000028","BK0028","BK0196","BK0082","BK0175","BK0188"],"gpt_icon":0},{"id":"2505260242","title":"国药一致:1月20日召开分析师会议,中金证券、开源证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2505260242","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505260242?lang=zh_cn&edition=full","pubTime":"2025-01-21 11:02","pubTimestamp":1737428542,"startTime":"0","endTime":"0","summary":"国大药房医保统筹占比一直很高。未来WB会在产品引入、服务模式等方面给予国大药房更多支持。未来企业包括国大药房在门店规模数上会有削减,核心是提高单店产出效率。国药一致主营业务:医药分销和医药零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100012429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","161027","BK0196","BK0028","BK0082","BK0175","BK0188","BK0185","BK0250","000028"],"gpt_icon":0},{"id":"2505265258","title":"国药一致(000028)1月20日主力资金净卖出2684.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505265258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505265258?lang=zh_cn&edition=full","pubTime":"2025-01-21 09:19","pubTimestamp":1737422386,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年1月20日收盘,国药一致报收于25.42元,下跌2.83%,换手率2.28%,成交量10.89万手,成交额2.76亿元。1月20日的资金流向数据方面,主力资金净流出2684.09万元,占总成交额9.74%,游资资金净流入241.86万元,占总成交额0.88%,散户资金净流入2442.22万元,占总成交额8.86%。国药一致主营业务:医药分销和医药零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100006875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0185","BK0188","BK0175","BK0250","000028","BK0196","BK0010","BK0082"],"gpt_icon":0},{"id":"2504941159","title":"国药控股:国药一致预计2024年归母净利润约5.61亿至7.6亿元同比下降52.48%至64.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504941159","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504941159?lang=zh_cn&edition=full","pubTime":"2025-01-20 08:31","pubTimestamp":1737333060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 国药控股(01099)公布,预计国药一致(000028.SZ)于2024年归属于上市公司股东的净利润为约5.61亿元-7.6亿元,同比下降52.48%-64.92%;预计扣非净利约4.97亿-6.96亿元,同比下降54.59%-67.58%。\n 根据商誉减值测试初步测试结果,国药一致本次拟计提的商誉及无形资产(品牌使用权和销售网络)减值准备金额约8.76亿元至10.7亿元,预计将减少报告期内归属于上市公司股东的净利润5.05亿元至6.18亿元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-01-20/doc-inefqmni9865205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01099","000028"],"gpt_icon":0},{"id":"2504623444","title":"国药控股(01099.HK)附属国药一致预计全年盈利跌逾52.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504623444","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504623444?lang=zh_cn&edition=full","pubTime":"2025-01-19 22:03","pubTimestamp":1737295380,"startTime":"0","endTime":"0","summary":"国药控股公布,附属国药一致发盈警,预计2024年度盈利介乎5.61亿至7.6亿人民币,按年下降52.5%-64.9%。年内,国药一致拟计提的商誉及无形资产减值准备金约8.76亿至10.7亿人币,将减少净利润5.05亿至6.18亿人民币。(港股报价延迟最少十五分钟。沽空资料截至 2025-01-17 16:25。)过往派息公布日期派息事项派息内容2024/10/28第三季业绩无派息2024/08/26中期业绩无派息2024/04/29第一季业绩无派息2024/03/25末期业绩股息:人民币 0.8700 AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240710142002364_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240710142002364_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411574/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["000028","BK0185","BK0188","BK1500","LU0640798160.USD","BK0196","BK0250","BK1197","BK0175","01099","BK1515","BK0010","BK0028","LU1115378108.SGD","BK0082"],"gpt_icon":0},{"id":"2504632064","title":"【国药一致预计2024年归母净利约5.61亿元-7.6亿元 同比下降52.48%-64.92%】国药一致预计2024年归属于上市公司股东的净利润为约5.61亿元-7.6亿元,同比下降52.48%-64.92%;预计扣非净利约4.97亿-6.96亿元,同比下降54.59%-67.58%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504632064","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504632064?lang=zh_cn&edition=full","pubTime":"2025-01-19 19:02","pubTimestamp":1737284555,"startTime":"0","endTime":"0","summary":"国药一致预计2024年归属于上市公司股东的净利润为约5.61亿元-7.6亿元,同比下降52.48%-64.92%;预计扣非净利约4.97亿-6.96亿元,同比下降54.59%-67.58%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/19190247594000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000028"],"gpt_icon":0},{"id":"2504222463","title":"国药控股(01099.HK):国药一致2024年度净利润预降52.48%-64.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504222463","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504222463?lang=zh_cn&edition=full","pubTime":"2025-01-19 19:00","pubTimestamp":1737284451,"startTime":"0","endTime":"0","summary":"格隆汇1月19日丨国药控股(01099.HK)发布公告,国药一致(000028.SZ)2024年归属于上市公司股东的净利润盈利5.61亿元–7.60亿元(人民币,下同),比上年同期下降52.48%-64.92%;扣除非经常性损益后的净利润盈利4.97亿元–6.96亿元,比上年同期下降54.59%-67.58%;基本每股收益盈利1.01元/股–1.37元/股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/19190047594014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01099","000028"],"gpt_icon":0},{"id":"2504633134","title":"国药控股(01099):国药一致(000028.SZ)预计2024年归母净利约5.61亿元-7.6亿元 同比下降52.48%-64.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504633134","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504633134?lang=zh_cn&edition=full","pubTime":"2025-01-19 18:55","pubTimestamp":1737284128,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股 公布,预计国药一致于2024年归属于上市公司股东的净利润为约5.61亿元-7.6亿元,同比下降52.48%-64.92%;预计扣非净利约4.97亿-6.96亿元,同比下降54.59%-67.58%。根据商誉减值测试初步测试结果,国药一致本次拟计提的商誉及无形资产减值准备金额约8.76亿元至10.7亿元,预计将减少报告期内归属于上市公司股东的净利润5.05亿元至6.18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK0188","BK0250","BK1197","LU0640798160.USD","BK0010","000028","01099","BK0082","BK0196","BK0028","BK0175","BK1500","LU1115378108.SGD","BK0185"],"gpt_icon":0},{"id":"2504201463","title":"国药控股:国药一致2024年度净利润预亏,预计下降52.48%-64.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504201463","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504201463?lang=zh_cn&edition=full","pubTime":"2025-01-19 18:50","pubTimestamp":1737283823,"startTime":"0","endTime":"0","summary":"金融界1月19日消息,国药一致预计2024年净利润为56,100万元至76,000万元,同比下降52.48%-64.92%;扣非后净利润为49,700万元至69,600万元,同比下降54.59%-67.58%。\n\n\r\n 责任编辑:钟离","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/19185047593992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000028","01099"],"gpt_icon":0},{"id":"2504152890","title":"国药一致(000028.SZ)发预减 2024年度净利润5.61亿–7.6亿元 同比下降52.48%-64.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504152890","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504152890?lang=zh_cn&edition=full","pubTime":"2025-01-17 20:21","pubTimestamp":1737116508,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药一致(000028.SZ)披露2024年度业绩预告,该公司预计报告期归属于上市公司股东的净利润5.61亿元–7.6亿元,同比下降52.48%-64.92%。扣除非经常性损益后的净利润4.97亿元–6.96亿元,同比下降54.59%-67.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1741676220575,"stockEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0188},{"period":"3month","weight":-0.112},{"period":"6month","weight":0.066},{"period":"1year","weight":-0.1573},{"period":"ytd","weight":-0.0944}],"compareEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":0.0189},{"period":"3month","weight":-0.0165},{"period":"6month","weight":0.2367},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0043}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"55656万元","survey":" 国药集团一致药业股份有限公司是集制药工业、医药批发、零售连锁为一体的医药上市公司,控股股东为国药控股有限公司。主要经营医药企业受托管理、资产重组,医药实业投资项目的咨询服务,举办医疗器械的展览展销,中药材、中成药、中药饮片、化学原料药、化学药制剂、抗生素、生化药品、生物制品的批发(经营期限以许可证为准)。公司坚持走研发、制药、分销、物流、零售一体化发展道路,旗下拥有致君制药、万乐公司、一致药店等公司,其中一致药店为国内最大规模的连锁药店之一,公司属下国大药房是全国销售规模领先的医药零售企业,是国内少数拥有全国性直营药品零售网络的企业之一。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}